An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity

Vaccine

Volumn 24, Issue 10, 2006, Pages 1615-1624

  Liu, Yong ^a   Zhou, Weiping ^a,b   You, Changxuan ^a,b   Zheng, Huaien ^a   You, Hong ^a   Liu, Hongmei ^a   Zhang, Dazhi ^a,b   Luo, Rongcheng ^c   Kay, Helen H ^a   Hermonat, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Adeno associated virus; Core gene; Cytotoxic T lymphocytes; Dendritic cells; Hepatitis C virus

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CORE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; PARVOVIRUS VECTOR; T6 ANTIGEN; VIRUS PROTEIN;

ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PARVOVIRUS INFECTION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS CORE; VIRUS GENE;

AUTOIMMUNITY; DENDRITIC CELLS; DEPENDOVIRUS; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; VIRAL CORE PROTEINS;

EID: 32544450298     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.09.055     Document Type: Article

References (49)

1. R. Purcell The hepatitis C virus: overview Hepatology 26 Suppl. 1 1997 1 14
2. A.M. Di Baseline, and J.H. Hoofnagle Optimal therapy of hepatitis C Hepatology 36 Suppl. 1 2002 121 127
3. A. Vogel, M.P. Manns, and C.P. Strassburg Autoimmunity and viruses Clin Liver Dis 6 2002 451 465
4. D.E. Baker Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C Rev Gastroenterol Disord 3 2003 93 109
5. M.W. Fried Side effects of therapy of hepatitisd C and their management Hepatology 36 Suppl. 1 2002 237 245
6. S. Mishiro, K. Takeda, and Y. Hoshi An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen Autoimmunity 10 1991 269 273
7. F. Bianchi Autoimmunity and HCV Recenti Progressi in Medicina 84 1993 774 778
8. C. Ferri, A.L. Zignego, S. Bombardieri, L. La Civita, G. Longombardo, and M. Monti Etiopathogenic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases and lymphomas Clin Exp Rheumatol 13 Suppl. 1995 135 140
9. R.H. Dennin, Z. Chen, and J. Wo The GOR47-1 sequence in human DNA encoding for a potential autoantigen in connection with hepatitis C-a sequence not only reserved for humans Zeitschrift fur Gastroenterologie 36 1998 877 882
10. S. Vitozzi, P. Lapierre, I. Djilali-Saiah, and F. Alvarez Autoantibody detection in type 2 autoimune hepatitis using a chimera recombinant protein J Immunol Method 262 2002 103 110
11. V. Barban, S. Fraysse-Corgier, G. Paranhos-Baccala, M. Petit, C. Manin, and Y. Berard Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient J Gen Virol 81 Part 2 2000 461 469
12. P. Obermayer-Straub, and M.P. Manns Hepatitis C and D, retroviruses and autoimmune manifestations J Autoimmun 16 2001 275 285
13. A.R. Kammer, S.H. van der Burg, B. Grabscheid, I.P. Hunziker, K.M. Kwappenberg, and J. Reichen Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition J Exp Med 190 1999 169 176
14. J. Koskinas, B.M. McFarlane, K.T. Nouri-Aria, C.J. Tibbs, M. Mizokami, and P.T. Donaldson Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C Gastroenterology 107 5 1994 1436 1442
15. R.A. Steinman The DC system and its role in immunogenicity Annu Rev Immunol 9 1991 271 296
16. I. Mellman, and R.M. Steinman Dendritic cells: specialized and regulated antigen processing machines Cell 106 2001 255 258
17. N. Romani, S. Gruner, D. Brang, E. Kampgen, A. Lnez, and B. Trockenbacher Proliferating dendritic cell progenitors in human blood J Exp Med 180 1994 83 89
18. M.A. Ossevoort, M.C. Feltkamp, K.J. van Veen, C.J. Melief, and W.M. Kast Dendritic cells as carriers for a cytotoxic T lymphocyte epitope based peptide vaccine in protection against a human papillomavirus type 16 induced tumor J Immunother Emphasis Tumor Immunol 18 1995 86 94
19. J.W. Young, and K. Inaba DCs as adjuvants for class I major histocompatibility complex-restricted antitumor immunity J Exp Med 183 1996 7 11
20. I. Jochmus, W. Osen, A. Altmann, B. Hofmann, A. Schneider, and L. Gissman Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7 derived peptide J Gen Virol 78 1997 1689 1695
21. B.G. Chen, Y.J. Shi, J.D. Smith, D. Choi, J.D. Geiger, and J.J. Mule The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood derived, cytokine driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4(+) T cells in vitro Blood 91 1998 4652 4661
22. A.D. Santin, P.L. Hermonat, A. Ravaggi, M. Chiriva-Internati, J.C. Hiserodt, and S. Pecorelli Generation of an MHC class I restricted cytotoxic T cell response against autologous cervical cancer tumor cells by lipofection of synthetic human papillomavirus types 16 and 18 E7 protein into primary dendritic cells J Virol 73 1999 5402 5410
23. Y. Liu, A.D. Santin, M. Mane, M. Chiriva-Internati, G.P. Parham, and A. Ravaggi Transduction and utility of the granulocyte macrophage-colony stimulating factor gene into dendritic cells by adeno-associated virus J Interferon Cytokine Res 20 2000 21 30
24. M.A. Batzer, V.A. Gudi, J.C. Mena, D.W. Foltz, R.J. Herrera, and P.L. Deininger Amplification dynamics of human specific (HS) Alu family members Nucleic Acids Res 19 1991 3619 3623
25. Y. Liu, M. Chiriva-Internati, F. Grizzi, E. Salati, J.J. Roman, and S. Lim Rapid induction of cytotoxic T cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector Cancer Gene Ther 8 2001 948 957
26. M. Chiriva-Internati, Y. Liu, E. Salati, W. Zhou, F. Grizzi, and J.J. Roman Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus-human papillomavirus type 16 E7 antigen transduction into dendritic cells Eur J Immunol 32 2002 30 38
27. M. Chiriva-Internati, Y. Liu, J.A. Weidanz, F. Grizzi, H. You, and W. Zhou Testing recombinant adeo-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24 Blood 102 2003 3100 3107
28. Y. Liu, M. Chiriva-Internati, C. You, R. Luo, H. You, and C.K. Prasad Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells Cancer Gene Ther 12 2005 304 312
29. You H, Liu Y, Cong M, You CX, Mehta JL, Hermonat PL. HBV genes induce cytotoxic T lymphocyte response upon adeno-associated virus (AAV) vector delivery into dencritic cells. J Viral Hepatitis 2005, in press.
30. R.F. Collaco, X. Cao, and J.P. Trempe A helper virus-free packaging system for recombinant adeno-associated virus vectors Gene 238 1999 397 405
31. A. Auricchio, M. Hildinger, E. O'Connor, G.-P. Gao, and J.M. Wilson Isolation of highly infectious and pure adeno- associated virus type 2 vectors with a single-step gravity-flow column Hum Gene Ther 12 2001 71 76
32. C. Sempoux, P. Starkel, M. Stevens, V. Van Den Berge, and Y. Horsmans Cytochrome P450 3 A proteins are expressed in B lymphocytes but not in T lymphocytes Pharmacogenetics 9 1999 263 265
33. C.L. Crespi Expression of cytochrome P450 cDNAs in human B lymphoblastoid cells: applications to toxicology and metabolite analysis Methods Enzymol 206 1991 123 129
34. W. Liu, D. Tan, Z. Zhang, X. Fan, and K. Ouyang Lymphocyte subset and its apoptosis in chronic hepatitis C Chung Hua Tsang Ping Tsa Chih 8 2000 269 271
35. S. Mishiro, Y. Hoshi, K. Takeda, A. Yoshikawa, T. Gotanda, and K. Takahashi Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process Lancet 336 1990 1400 1403
36. Y. Fukuda, N. Ishida, T. Noguchi, A. Kappas, and S. Sassa Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2 and IIIA3 in human hepatoma cells Biochem Biophys Res Commun 182 1992 960 965
37. E.M. Shevach, R.S. McHugh, C.A. Piccirillo, and A.M. Thornton Control of T-cell activation by CD4+ CD25+ suppressor T cells Immunol Rev 182 2001 58 67
38. A. Gallimore, and S. Sakaguchi Regulation of tumor immunity by CD25+ T cells Immunology 107 2002 5 9
39. S.F. Ziegler, F. Ramsdell, and M.R. Alderson The activation antigen CD69 Stem Cells 12 1994 456 465
40. K.O. Schowengerdt, F.J. Fricker, Bahjat, and S.T. Kuntz Increased expression of the lymphocyte early activation marker CD69 in oerioheral blood correlates with histologic evidence of cardiac allograft rejection Transplantation 69 2000 2102 2107
41. J.T. Gerlach, H.M. Diepolder, M.C. Jung, N.H. Gruener, W.W. Schraut, and R. Zachoval Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in actute hepatitis C Gastroenterology 117 1999 933 941
42. A. Ito, T. Kanto, N. Kuzushita, T. Tatsumi, Y. Sugimoto, and T. Miyagi Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-loaded dendritic cells J Gastroenterol Hepatol 16 2001 309 316
43. M. Jackson, B. Smith, and D.J. Bevitt Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individuals J Med Virol 58 1999 239 246
44. K.M. Chang, B. Rehermann, J.G. McHutchison, M. Steward, G.L. Toms, and M.F. Bassendine Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus J Clin Invest 100 1997 2376 2385
45. J.Y. Sun, R.S. Krouse, S.J. Forman, D. Senitzer, I. Sniecinski, and S. Chatterjee Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitro Cancer Res 62 2002 3175 3183
46. J.Y. Sun, D. Senitzer, S.J. Forman, S. Chatterjee, and KK. Wong Jr. Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytes Cancer Immunol Immunother 52 2003 761 770
47. K.Y. Tsang, M. Zhu, J. Even, J. Gulley, P. Arlen, and J. Schlom The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells Cancer Res 61 2001 7568 7576
48. L.L. Lanier, S. O'Fallon, C. Somoza, J.H. Phillips, P.S. Linsley, and K. Okumura CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL J Immunol 154 1995 97 105
49. Y. Hiasa, and M. Onji Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes Biochem Biophys Res Commun 249 1998 90 95